| |
| |
|
| Insider
Information: |
Ferrari Louis |
| Relationship: |
President and CEO, Dir... |
| City: |
East Brunswick |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
307,439 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
307,439 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Savient Pharmaceuticals Inc |
SVNTQ |
President and CEO, Dir... |
2013-05-22 |
307,439 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SVNTQ |
Savient Pharmaceuticals I... |
President and CEO |
• • – |
2013-05-22 |
4 |
AS |
$0.57 |
$581 |
D/D |
(1,020) |
307,439 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President and CEO |
• • – |
2013-02-25 |
4 |
AS |
$0.99 |
$371 |
D/D |
(375) |
295,996 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President and CEO |
• – – |
2013-02-04 |
4 |
AS |
$1.01 |
$62,854 |
D/D |
(62,200) |
296,371 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President and CEO |
• – – |
2012-11-26 |
4 |
AS |
$1.16 |
$1,102 |
D/D |
(950) |
358,571 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President and CEO |
• – – |
2012-08-31 |
4 |
A |
$1.12 |
$2,731 |
D/D |
2,434 |
359,521 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President and CEO |
• – – |
2012-08-22 |
4 |
AS |
$1.00 |
$986 |
D/D |
(984) |
348,577 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President and CEO |
• – – |
2012-05-31 |
4 |
A |
$0.62 |
$3,625 |
D/D |
5,888 |
357,087 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, North American Commerical |
• – – |
2012-05-22 |
4 |
AS |
$0.82 |
$772 |
D/D |
(942) |
349,561 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President and CEO |
• – – |
2012-02-29 |
4 |
A |
$1.71 |
$4,480 |
D/D |
2,622 |
351,199 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, North American Commerical |
• – – |
2012-02-22 |
4 |
AS |
$2.06 |
$8,446 |
D/D |
(4,100) |
350,503 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, N American Commerical Ops |
• – – |
2012-02-01 |
4 |
A |
$2.26 |
$700,600 |
D/D |
310,000 |
354,603 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, N American Commerical Ops |
• – – |
2011-11-30 |
4 |
A |
$2.13 |
$812 |
D/D |
381 |
44,603 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, North American Commerical |
• – – |
2011-11-21 |
4 |
B |
$2.29 |
$9,160 |
D/D |
4,000 |
44,000 |
2.74 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, N American Commerical Ops |
• – – |
2011-08-31 |
4 |
A |
$3.66 |
$813 |
D/D |
222 |
44,222 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, North American Commerical |
• – – |
2011-02-21 |
4 |
A |
$9.98 |
$399,200 |
D/D |
40,000 |
40,000 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, North American Commerical |
• – – |
2011-02-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,000 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
